Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2015 Nov 17;19(1):72–78. doi: 10.1038/pcan.2015.53

Figure 2.

Figure 2

Figure 2

Kaplan-Meier plots for clinical/radiographic PFS, showing subsets according to prior use of abiraterone or ketoconazole. A) No prior use of abiraterone or ketoconazole (hazard ratio 0.49 [0.29–0.84]), B) Prior use of abiraterone or ketoconazole (hazard ratio 0.96 [0.59–1.57]).